Jul
18

Accelerated Clinical Trial Agreement Announcement

SPRI is pleased to announce that we are now part of the Accelerated Clinical Trial Agreement program (ACTA). This allows us to significantly reduce contract negotiation time and get your project up and running faster.

Jul
11

July 2017

150th subject (75% complete) enrolled in the Advanced Parkinson’s Post Marketing Study as of 07 July. On schedule to meet enrollment by the end of 2017. Congratulations to the 52 active sites across 10 countries!

May
01

May 2017

Enrollment completed for all cohorts in a Proof of Concept Open-label, Dose-Escalation Study in subjects with Mild to Moderate Ulcerative Proctitis (UP) or Ulcerative Proctosigmoiditis (UPS). Congratulations to our Georgian sites!

Apr
01

April 2017

EASL (Amsterdam 2017). Exciting to see the series of LOWR abstracts at EASL highlighting the Hepatitis Delta studies with Lonafarnib. SPRI clinical has enjoyed the great partnership with the sites in advancing the understanding of Hepatitis Delta.

Mar
01

March 2017

Wow! 24 thousand participants treated in Mass Drug Administration (Haiti, India, Indonesia, & PNG) in 5 months. Great collaboration with the DOLF (Death to Oncho and Lymphatic Filiaris) team from Washington University and the Bill and Melinda Gates Foundation!

Page: